Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.
0/5 보강
APA
Wadsley J, Ainsworth G, et al. (2023). Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.. Thyroid : official journal of the American Thyroid Association, 33(9), 1119-1123. https://doi.org/10.1089/thy.2022.0707
MLA
Wadsley J, et al.. "Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.." Thyroid : official journal of the American Thyroid Association, vol. 33, no. 9, 2023, pp. 1119-1123.
PMID
37565288 ↗